https://www.selleckchem.com/products/icrt3.html
Osteoporosis is frequently accompanied by iron disorders. Calcitonin (CT) was approved as a clinical drug to treat osteoporosis. Hepcidin is a peptide hormone that is secreted by the liver and controls body iron homeostasis. Hepcidin deficiency leads to iron overload diseases. This study was aimed at investigating the effect of CT on hepatic hepcidin and the mechanism by which CT modulates hepatic hepcidin pathways and iron metabolism. RT-PCR, Western blot, ELISA and siRNA were used to detect the effect of CT on iron metabolism in vivo an
Like
Comment
Share
